Constantine Davides
Stock Analyst at JMP Securities
(n/a)
# 4,689
Out of 4,842 analysts
96
Total ratings
n/a
Success rate
-16.08%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx | Maintains: Market Outperform | $11 → $14 | $12.25 | +14.29% | 8 | May 13, 2025 | |
| CERT Certara | Reiterates: Market Perform | n/a | $11.33 | - | 3 | May 6, 2025 | |
| PRVA Privia Health Group | Reiterates: Market Outperform | $29 | $23.08 | +25.65% | 4 | Apr 28, 2025 | |
| EVH Evolent Health | Reiterates: Market Outperform | $13 | $7.64 | +70.16% | 8 | Apr 28, 2025 | |
| AGL agilon health | Reiterates: Market Perform | n/a | $2.35 | - | 4 | Apr 28, 2025 | |
| USPH U.S. Physical Therapy | Reiterates: Market Outperform | $113 | $75.42 | +49.83% | 2 | Apr 22, 2025 | |
| OPCH Option Care Health | Reiterates: Market Outperform | $36 | $31.74 | +13.44% | 4 | Apr 22, 2025 | |
| ADUS Addus HomeCare | Maintains: Market Outperform | $150 | $113.27 | +32.43% | 2 | Apr 10, 2025 | |
| AXGN Axogen | Maintains: Market Outperform | $20 → $26 | $10.96 | +137.23% | 1 | Feb 26, 2025 | |
| AMT American Tower | Maintains: Market Outperform | $225 → $248 | $212.46 | +16.73% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $34 → $33 | $21.15 | +56.03% | 9 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $28.07 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $13.44 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $105 → $107 | $101.48 | +5.44% | 4 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.25 | - | 3 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $31.81 | - | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.66 | +216.27% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $1.28 | +9,703.92% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $20.33 | -26.22% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $19.12 | +17.68% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $2.05 | +314.63% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $0.85 | +1,552.31% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $8.00 | +4,400.00% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $540 | $0.83 | +64,624.92% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $0.90 | +4,366.28% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.49 | +1,120.26% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $80 | $1.04 | +7,592.31% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $20 | $0.01 | +344,727.59% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $1.10 | +7,627.27% | 2 | Sep 23, 2022 |
OptimizeRx
May 13, 2025
Maintains: Market Outperform
Price Target: $11 → $14
Current: $12.25
Upside: +14.29%
Certara
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $11.33
Upside: -
Privia Health Group
Apr 28, 2025
Reiterates: Market Outperform
Price Target: $29
Current: $23.08
Upside: +25.65%
Evolent Health
Apr 28, 2025
Reiterates: Market Outperform
Price Target: $13
Current: $7.64
Upside: +70.16%
agilon health
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $2.35
Upside: -
U.S. Physical Therapy
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $113
Current: $75.42
Upside: +49.83%
Option Care Health
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $36
Current: $31.74
Upside: +13.44%
Addus HomeCare
Apr 10, 2025
Maintains: Market Outperform
Price Target: $150
Current: $113.27
Upside: +32.43%
Axogen
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $10.96
Upside: +137.23%
American Tower
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $212.46
Upside: +16.73%
Feb 24, 2025
Maintains: Market Outperform
Price Target: $34 → $33
Current: $21.15
Upside: +56.03%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $28.07
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $13.44
Upside: -
Dec 10, 2024
Maintains: Market Outperform
Price Target: $105 → $107
Current: $101.48
Upside: +5.44%
Sep 19, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $21.25
Upside: -
Jul 16, 2024
Initiates: Market Perform
Price Target: n/a
Current: $31.81
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.66
Upside: +216.27%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $1.28
Upside: +9,703.92%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $20.33
Upside: -26.22%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $19.12
Upside: +17.68%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $2.05
Upside: +314.63%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $0.85
Upside: +1,552.31%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $8.00
Upside: +4,400.00%
Apr 13, 2023
Reiterates: Buy
Price Target: $540
Current: $0.83
Upside: +64,624.92%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $0.90
Upside: +4,366.28%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.49
Upside: +1,120.26%
Sep 28, 2022
Maintains: Buy
Price Target: $140 → $80
Current: $1.04
Upside: +7,592.31%
Sep 28, 2022
Maintains: Buy
Price Target: $40 → $20
Current: $0.01
Upside: +344,727.59%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $1.10
Upside: +7,627.27%